More articles from INFLAMMATION AND IMMUNOPHARMACOLOGY

You have access
Lipopolysaccharide Induces Epithelium- and Prostaglandin E₂-Dependent Relaxation of Mouse Isolated Trachea through Activation of Cyclooxygenase (COX)-1 and COX-2
Rowan W. Balzary and Thomas M. Cocks

Journal of Pharmacology and Experimental Therapeutics May 2006, 317 (2) 806-812; DOI: https://doi.org/10.1124/jpet.105.097634
You have access
Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship
Gautham K. Rao and Norbert E. Kaminski

Journal of Pharmacology and Experimental Therapeutics May 2006, 317 (2) 820-829; DOI: https://doi.org/10.1124/jpet.105.100503
You have access
Protease-Activated Receptor-2 Peptides Activate Neurokinin-1 Receptors in the Mouse Isolated Trachea
Hugh T. Abey, David P. Fairlie, James D. Moffatt, Rowan W. Balzary and Thomas M. Cocks

Journal of Pharmacology and Experimental Therapeutics May 2006, 317 (2) 598-605; DOI: https://doi.org/10.1124/jpet.105.097121
You have access
A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes
Hoon-Suk Cha, David L. Boyle, Tomoyuki Inoue, Reineke Schoot, Paul P. Tak, Polly Pine and Gary S. Firestein

Journal of Pharmacology and Experimental Therapeutics May 2006, 317 (2) 571-578; DOI: https://doi.org/10.1124/jpet.105.097436
You have access
Discovery of a Dual-Function Peptide That Combines Aminopeptidase N Inhibition and Kinin B₁ Receptor Antagonism
Lajos Gera, Jean-Philippe Fortin, Albert Adam, John M. Stewart and François Marceau

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 300-308; DOI: https://doi.org/10.1124/jpet.105.095661
You have access
In Vitro and in Vivo Anti-Inflammatory Activity of a Seed Preparation Containing Phenethylisothiocyanate
Moul Dey, David Ribnicky, Anvar G. Kurmukov and Ilya Raskin

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 326-333; DOI: https://doi.org/10.1124/jpet.105.096511
You have access
A Novel, Selective, and Orally Available Antagonist for CC Chemokine Receptor 3
Tatsuaki Morokata, Keiko Suzuki, Yohei Masunaga, Katsunari Taguchi, Koichiro Morihira, Ippei Sato, Masahiro Fujii, Satoko Takizawa, Yuichi Torii, Naoyoshi Yamamoto, Masayuki Kaneko, Toshimitsu Yamada, Koichiro Takahashi and Yasuaki Shimizu

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 244-250; DOI: https://doi.org/10.1124/jpet.105.097048
You have access
Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A_2A and A_2B but Not the A₃ Adenosine Receptor
Laura M. Kreckler, Tina C. Wan, Zhi-Dong Ge and John A. Auchampach

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 172-180; DOI: https://doi.org/10.1124/jpet.105.096016
You have access
In Vivo Characterization of the Novel Imidazopyridine BYK191023 [2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a Potent and Highly Selective Inhibitor of Inducible Nitric-Oxide Synthase
Martin D. Lehner, Degenhard Marx, Rainer Boer, Andreas Strub, Christian Hesslinger, Manfrid Eltze, Wolf-Rüdiger Ulrich, Frank Schwoebel, Ralph Theo Schermuly and Johannes Barsig

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 181-187; DOI: https://doi.org/10.1124/jpet.105.098673
You have access
Anti-Inflammatory Activity in Vitro and in Vivo of the Protein Farnesyltransferase Inhibitor Tipifarnib
Xiaohua Xue, Kuei-Tai A. Lai, Jing-Feng Huang, Yin Gu, Lars Karlsson and Anne Fourie

Journal of Pharmacology and Experimental Therapeutics April 2006, 317 (1) 53-60; DOI: https://doi.org/10.1124/jpet.105.095976

Main menu

User menu

Search

More articles from INFLAMMATION AND IMMUNOPHARMACOLOGY

Pages

Navigate

More Information

ASPET's Other Journals